Literature DB >> 17210186

Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity.

Joerg R Weber1, Elaine I Tuomanen.   

Abstract

Bacterial meningitis is still an important infectious disease causing death and disability. Invasive bacterial infections of the CNS generate some of the most powerful inflammatory responses known in medicine. Although the components of bacterial cell surfaces are now chemically defined in exquisite detail and the interaction with several receptor pathways has been discovered, it is only very recently that studies combining these advanced biochemical and cell biological tools have been done. Additional to the immunological response direct bacterial toxicity has been identified as an important contributor to neuronal damage. A detailed understanding of the complex interaction of bacterial toxicity and host response may generate opportunities for innovative and specific neuroprotective therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210186     DOI: 10.1016/j.jneuroim.2006.11.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  30 in total

Review 1.  The pneumococcus: epidemiology, microbiology, and pathogenesis.

Authors:  Birgitta Henriques-Normark; Elaine I Tuomanen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Leukoencephalopathy in pneumococcal meningitis: a diagnostic pitfall and treatment challenge.

Authors:  Dragan Lepur; Vjerislav Peterković; Klaudija Višković; Nevija Kalabrić Lepur
Journal:  Neurol Sci       Date:  2010-06-05       Impact factor: 3.307

4.  Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice.

Authors:  Vjerislav Peterković; Vladimir Trkulja; Marko Kutleša; Vladimir Krajinović; Dragan Lepur
Journal:  J Neurol       Date:  2011-06-25       Impact factor: 4.849

5.  FTIR imaging of brain tissue reveals crystalline creatine deposits are an ex vivo marker of localized ischemia during murine cerebral malaria: general implications for disease neurochemistry.

Authors:  Mark J Hackett; Joonsup Lee; Fatima El-Assaad; James A McQuillan; Elizabeth A Carter; Georges E Grau; Nicholas H Hunt; Peter A Lay
Journal:  ACS Chem Neurosci       Date:  2012-09-11       Impact factor: 4.418

Review 6.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

7.  A proteomic approach for the diagnosis of bacterial meningitis.

Authors:  Sarah Jesse; Petra Steinacker; Stefan Lehnert; Martin Sdzuj; Lukas Cepek; Hayrettin Tumani; Olaf Jahn; Holger Schmidt; Markus Otto
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

9.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

10.  Identification of IbeR as a stationary-phase regulator in meningitic Escherichia coli K1 that carries a loss-of-function mutation in rpoS.

Authors:  Feng Chi; Ying Wang; Timothy K Gallaher; Chun-Hua Wu; Ambrose Jong; Sheng-He Huang
Journal:  J Biomed Biotechnol       Date:  2009-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.